• Baicalin and Adult Visual Plasticity: What Mice Show

  2026-10-13

  A 2026 mouse study reports that Baicalin reactivated ocular dominance plasticity and improved visual measures in an adult amblyopia model. The findings support a preclinical hypothesis involving reduced cortical inhibition, but they do not establish human efficacy, long-term benefit, mechanism, or safety.

• TMRE Evidence Gaps in Sodium-Driven Mitochondrial Failure

  2026-10-12

  This overview separates the reported sodium-driven mechanism in Qiao et al. from what a TMRE-based readout can establish, emphasizing missing head-to-head assay comparisons, model boundaries, and the distinction between mitochondrial membrane potential and broader energy failure.

• Bile Acid Subtypes in Colorectal Cancer

  2026-10-12

  Feng et al. associate bile acid metabolism subtypes with survival, immune-cell estimates, and expression of CLCA1, UGT2A3, and ZG16 in colorectal cancer. The findings are clinically suggestive but primarily observational and computational; they do not establish causality, treatment response, or clinical utility.

• EX 527 and SIRT1 in Aging Bone: Evidence Boundaries

  2026-10-11

  Liu et al. report that SIRT1 supports endothelial and osteogenic activity in aging-bone models, but the supplied evidence does not establish clinical efficacy or show that SIRT1 inhibition produces the opposite phenotype. EX 527 (SEN0014196) is best interpreted as a pharmacological tool for studying SIRT1 catalytic activity, with supplier-reported selectivity that remains assay- and provenance-dependent.

• Protein A/G Magnetic Co-IP/IP Kit: Evidence Guide

  2026-10-09

  A source-grounded overview of how Protein A/G magnetic immunoprecipitation supports protein-complex research, what the UBC9–PINK1 Parkinson’s disease study found, and why co-IP evidence should be interpreted with attention to controls, model scope, and independent validation.

• Isradipine: Reading Calcium-Channel Evidence

  2026-10-09

  Isradipine (Dynacirc) is examined as a mechanistic tool for separating L-type calcium-channel effects from broader neuronal calcium pharmacology. This evidence-focused guide connects the compound’s research uses with the interpretive lessons of a landmark v-agatoxin study while defining limits for neurovascular and hypertension research.

• In Vivo CAR T Cells for Mouse Lupus: Study Analysis

  2026-10-08

  A 2026 study reports an in vivo CAR T-cell strategy that uses CD5-targeted lipid nanoparticles to deliver CD19 CAR mRNA in a mouse model of systemic lupus erythematosus. The approach depleted disease-associated B-cell populations and improved immunological and tissue-level disease measures without ex vivo cell manufacturing or lymphodepletion, although translation to human SLE remains unestablished.

• Protein A/G Magnetic Co-IP/IP Kit in PD Research

  2026-10-08

  Explore how the Protein A/G Magnetic Co-IP/IP Kit can support mechanistic interpretation of UBC9–PINK1 biology in Parkinson’s disease research. This evidence-centered guide distinguishes physical association, SUMOylation, and functional rescue while defining the kit’s practical scope and limitations.

• Isradipine (Dynacirc): From L-Type Biology to Translation

  2026-10-07

  Isradipine (Dynacirc) offers a translationally relevant lens on L-type calcium-channel biology, linking vascular smooth muscle relaxation with investigations of neuronal calcium dysregulation. This thought-leadership analysis places the compound alongside evidence from Sidach and Mintz on calcium-channel pharmacology, while emphasizing the limits of extrapolating toxin selectivity data to isradipine, disease models, or clinical neuroprotection.

• Five Questions About TMRE Mitochondrial Potential

  2026-10-07

  A source-grounded overview of how TMRE relates to mitochondrial membrane potential, what the NECSO study actually shows, and why fluorescence should be interpreted as one piece of evidence rather than a standalone diagnosis of apoptosis, mitochondrial failure, or sodium-overload necrosis.

• ERAD Hijacking for Transmembrane Protein Degradation

  2026-10-06

  Song and colleagues report ERAD-engaging chimeras (ERADECs), a targeted protein degradation strategy that recruits the ER E3 ligase SYVN1 to remove transmembrane proteins. The study links a desonide-derived warhead to potent PD-L1 degradation and tumor-suppression effects while also presenting evidence for activity against mutant huntingtin.

• BATF2–ATF3 Signaling and Co-IP Evidence in IVDD

  2026-10-06

  A source-grounded overview of the reported BATF2–ATF3 mechanism in intervertebral disc degeneration and the conceptual role of Protein A/G magnetic co-immunoprecipitation in evaluating protein-complex evidence. The discussion separates published findings from supplier claims and identifies key limitations, including the inability of co-immunoprecipitation alone to establish direct binding, causality, or therapeutic efficacy.

• Brassinolide: From Plant Signal to Translation

  2026-10-05

  A source-grounded perspective on Brassinolide, linking plant bioassays with early cancer and diabetes research while defining the evidence needed for translational confidence.

• Sodium Overload, Mitochondria, and NECSO

  2026-10-05

  Qiao and colleagues identify mitochondrial energy failure as a central mechanism linking TRPM4-mediated sodium influx to necrosis by sodium overload, or NECSO. Their model connects mitochondrial sodium and calcium remodeling with impaired oxidative phosphorylation, ATP depletion, Na+/K+-ATPase failure, cellular swelling, and lysis, while also defining important limits for interpreting mitochondrial readouts.

• Sodium Overload and Mitochondrial Failure in NECSO

  2026-10-04

  A 2025 Nature Communications study proposes that sodium overload-induced necrosis, or NECSO, is executed through mitochondrial energy failure rather than through osmotic disruption alone. The reported mechanism links TRPM4-dependent sodium entry to altered mitochondrial ion handling, impaired oxidative phosphorylation, ATP depletion, and eventual loss of cell-volume control.

8684 records 2/579 page Previous Next 12345 下5页 Last page